BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16094109)

  • 1. Are somatostatin analogs therapeutic alternatives in the management of head and neck paragangliomas?
    Duet M; Guichard JP; Rizzo N; Boudiaf M; Herman P; Tran Ba Huy P
    Laryngoscope; 2005 Aug; 115(8):1381-4. PubMed ID: 16094109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of somatostatin receptor imaging in patients with suspected head and neck paragangliomas.
    Schmidt M; Fischer E; Dietlein M; Michel O; Weber K; Moka D; Stennert E; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1571-80. PubMed ID: 12458390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck.
    Duet M; Sauvaget E; Pételle B; Rizzo N; Guichard JP; Wassef M; Le Cloirec J; Herman P; Tran Ba Huy P
    J Nucl Med; 2003 Nov; 44(11):1767-74. PubMed ID: 14602858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Scintigraphy by l'Octreoscan in the management of head and neck paragangliomas].
    Duet M; Sauvaget E; Guichard JP; Petelle B; Ledjedel S; Herman P; Tran Ba Huy P
    Ann Otolaryngol Chir Cervicofac; 2002 Dec; 119(6):315-21. PubMed ID: 12527839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography.
    Michałowska I; Ćwikła JB; Pęczkowska M; Furmanek MI; Buscombe JR; Michalski W; Prejbisz A; Szperl M; Malinoc A; Moczulski D; Szutkowski Z; Kawecki A; Antoniewicz J; Pęczkowski P; Lewczuk A; Otto M; Cichocki A; Bednarek-Tupikowska G; Kabat M; Janaszek-Sitkowska H; Przybyłowska K; Janas J; Neumann HP; Januszewicz A
    Neuroendocrinology; 2015; 101(4):321-30. PubMed ID: 25791839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas.
    Koopmans KP; Jager PL; Kema IP; Kerstens MN; Albers F; Dullaart RP
    J Nucl Med; 2008 Aug; 49(8):1232-7. PubMed ID: 18632829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide scintigraphy for the detection of paragangliomas.
    Kwekkeboom DJ; van Urk H; Pauw BK; Lamberts SW; Kooij PP; Hoogma RP; Krenning EP
    J Nucl Med; 1993 Jun; 34(6):873-8. PubMed ID: 8389841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: patient with multiple paragangliomas treated with long acting somatostatin analogue.
    Tonyukuk V; Emral R; Temizkan S; Sertçelik A; Erden I; Corapçioğlu D
    Endocr J; 2003 Oct; 50(5):507-13. PubMed ID: 14614206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of octreotide therapy in progressive head and neck paragangliomas: case series.
    van Hulsteijn LT; van Duinen N; Verbist BM; Jansen JC; van der Klaauw AA; Smit JW; Corssmit EP
    Head Neck; 2013 Dec; 35(12):E391-6. PubMed ID: 23606330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and follow-up of head and neck paragangliomas. Contributions of nuclear medicine].
    Tamayo Alonso P; Ruano Pérez R; Muñoz Herrera A
    Acta Otorrinolaringol Esp; 2009 Feb; 60 Suppl 1():68-75. PubMed ID: 19245777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.
    Bevan JS; Atkin SL; Atkinson AB; Bouloux PM; Hanna F; Harris PE; James RA; McConnell M; Roberts GA; Scanlon MF; Stewart PM; Teasdale E; Turner HE; Wass JA; Wardlaw JM
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4554-63. PubMed ID: 12364434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide scintigraphy for the detection of paragangliomas.
    Telischi FF; Bustillo A; Whiteman ML; Serafini AN; Reisberg MJ; Gomez-Marin O; Civantos FJ; Balkany TJ
    Otolaryngol Head Neck Surg; 2000 Mar; 122(3):358-62. PubMed ID: 10699810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and management of cervical paragangliomas: the Freiburg experience].
    Boedeker CC; Ridder GJ; Neumann HP; Maier W; Schipper J
    Laryngorhinootologie; 2004 Sep; 83(9):585-92. PubMed ID: 15372340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined endovascular and surgical treatment of head and neck paragangliomas--a team approach.
    Persky MS; Setton A; Niimi Y; Hartman J; Frank D; Berenstein A
    Head Neck; 2002 May; 24(5):423-31. PubMed ID: 12001071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of efficacy of octreotide therapy in patients with acromegaly.
    Colao A; Ferone D; Lastoria S; Marzullo P; Cerbone G; Di Sarno A; Longobardi S; Merola B; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2356-62. PubMed ID: 8964877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of somatostatin receptors in tumors in the area of the head and neck and their clinical importance].
    Kau RJ; Wagner-Manslau C; Saumweber DM; Arnold W
    Laryngorhinootologie; 1994 Jan; 73(1):21-6. PubMed ID: 7908199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative gamma probe detection of head and neck paragangliomas with 111In-pentetreotide: a pilot study.
    Filippi L; Valentini FB; Gossetti B; Gossetti F; De Vincentis G; Scopinaro F; Massa R
    Tumori; 2005; 91(2):173-6. PubMed ID: 15948547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic evaluation of temporal paragangliomas].
    Szymańska A; Gołabek W; Szymański M; Morshed K; Trojanowska A
    Otolaryngol Pol; 2007; 61(6):931-6. PubMed ID: 18546938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome.
    Tabarin A; Valli N; Chanson P; Bachelot Y; Rohmer V; Bex-Bachellerie V; Catargi B; Roger P; Laurent F
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1193-202. PubMed ID: 10199752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of long-acting octreotide in the treatment of thymic tumors: results of a pilot trial.
    Longo F; De Filippis L; Zivi A; Vitolo D; Del Signore E; Gori B; Diso D; Anile M; Venuta F; De Giacomo T; Coloni CF
    Am J Clin Oncol; 2012 Apr; 35(2):105-9. PubMed ID: 21325939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.